Lipid Sciences, Inc.
Records under this name other than patents Lipid Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,361,739 | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content Term ended Ended no later than Mar 8, 2024 · From the USPTO record | Term ended | Ended no later than Mar 8, 2024 | From the USPTO record |
| US 7,375,191 | Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content Formerly held Term ended Ended no later than Mar 8, 2024 · Medium confidence | Term ended | Ended no later than Mar 8, 2024 | Medium confidence |
| US 7,393,826 | Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content Formerly held Term ended Ended no later than Mar 8, 2024 · Medium confidence | Term ended | Ended no later than Mar 8, 2024 | Medium confidence |
| US 8,637,460 | Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content Formerly held Term ended Ended no later than Mar 8, 2024 · Low confidence | Term ended | Ended no later than Mar 8, 2024 | Low confidence |
| US 8,268,787 | Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content Term ended Term ended Jan 20, 2024 · Medium confidence | Term ended | Term ended Jan 20, 2024 | Medium confidence |
| US 8,506,968 | SARS Vaccine Compositions and Methods of Making and Using Them Formerly held Lapsed on the fee record Ended Aug 13, 2017 · Medium confidence | Lapsed on the fee record | Ended Aug 13, 2017 | Medium confidence |
| US 8,435,531 | Method of Treating Cancer Cells to Create a Modified Cancer Cell That Provokes an Immunogenic Response Formerly held Lapsed on the fee record Ended May 7, 2017 · Low confidence | Lapsed on the fee record | Ended May 7, 2017 | Low confidence |
| US 7,439,052 | Method of Making Modified Immunodeficiency Virus Particles Formerly held Lapsed on the fee record Ended Oct 21, 2016 · High confidence | Lapsed on the fee record | Ended Oct 21, 2016 | High confidence |
| US 7,407,662 | Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Formerly held Lapsed on the fee record Ended Aug 5, 2016 · Medium confidence | Lapsed on the fee record | Ended Aug 5, 2016 | Medium confidence |
| US 7,407,663 | Modified Immunodeficiency Virus Particles Formerly held Lapsed on the fee record Ended Aug 5, 2016 · High confidence | Lapsed on the fee record | Ended Aug 5, 2016 | High confidence |